dipyridamole has been researched along with Peripheral Vascular Diseases in 23 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole nuclear myocardial perfusion test is a safe and effective alternative to exercise nuclear perfusion testing for detecting myocardial ischemia." | 7.71 | Dipyridamole-induced ST-segment elevation indicative of transmural myocardial ischemia--a case report. ( Chaudhry, K; Pillai, N; Rachko, M; Safi, AM; Stein, RA, 2001) |
| "Using the key terms acute coronary syndrome, atherothrombosis, ischemic stroke, myocardial infarction, MI, peripheral arterial disease, TIA, transient ischemic attack, unstable angina,aspirin,ticlopidine,dipyridamole, and clopidogrel, we searched the MEDLINE database as well as the trial register of the Cochrane Groups to identify studies published from 1960 to August 2004." | 4.82 | Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. ( Anand, SS; Tran, H, 2004) |
| "Dipyridamole nuclear myocardial perfusion test is a safe and effective alternative to exercise nuclear perfusion testing for detecting myocardial ischemia." | 3.71 | Dipyridamole-induced ST-segment elevation indicative of transmural myocardial ischemia--a case report. ( Chaudhry, K; Pillai, N; Rachko, M; Safi, AM; Stein, RA, 2001) |
| "For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched June 2014) and the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 5)." | 2.52 | Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. ( Acosta, S; Bedenis, R; Lethaby, A; Maxwell, H; Prins, MH, 2015) |
| "Aspirin therapy was associated with a reduction in the secondary outcome of nonfatal stroke (52 of 2823 vs 76 of 2446; RR, 0." | 2.45 | Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. ( Berger, JS; Hiatt, WR; Kittelson, JM; Krantz, MJ, 2009) |
| "We searched the Cochrane Peripheral Vascular Diseases Group's trials register (last searched April 2004), the Cochrane Central Register of Controlled trials (CENTRAL Issue 2, 2004), MEDLINE and EMBASE (last searched June 2004)." | 2.43 | Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. ( Büller, HR; Dörffler-Melly, J; Koopman, MM; Prins, MH, 2005) |
| "Dipyridamole treatment quickly restored ischaemic hindlimb blood flow, increased vascular density and cell proliferation, and enhanced collateral artery perfusion compared with control treatments." | 1.36 | Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. ( Branch, B; Hood, J; Illum, S; Kevil, CG; Pardue, S; Patel, RP; Pattillo, CB; Teng, X; Thoma, S; Venkatesh, PK, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (47.83) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedenis, R | 1 |
| Lethaby, A | 1 |
| Maxwell, H | 1 |
| Acosta, S | 1 |
| Prins, MH | 2 |
| Berger, JS | 1 |
| Krantz, MJ | 1 |
| Kittelson, JM | 1 |
| Hiatt, WR | 1 |
| Takagi, H | 1 |
| Umemoto, T | 1 |
| Venkatesh, PK | 1 |
| Pattillo, CB | 1 |
| Branch, B | 1 |
| Hood, J | 1 |
| Thoma, S | 1 |
| Illum, S | 1 |
| Pardue, S | 1 |
| Teng, X | 1 |
| Patel, RP | 1 |
| Kevil, CG | 1 |
| Dörffler-Melly, J | 2 |
| Schmidli, J | 1 |
| Mahler, F | 1 |
| Moura, L | 1 |
| Zamorano, J | 1 |
| de Isla, LP | 1 |
| Almeria, C | 1 |
| Rodrigo, JL | 1 |
| Sánchez-Harguindey, L | 1 |
| Macaya, C | 1 |
| Aronow, WS | 1 |
| Tran, H | 1 |
| Anand, SS | 1 |
| Koopman, MM | 1 |
| Büller, HR | 1 |
| Lorenzen, ND | 1 |
| Eldrup, N | 1 |
| Laustsen, J | 1 |
| Mocini, D | 1 |
| Uguccioni, M | 1 |
| Galli, C | 1 |
| Bianchi, C | 1 |
| Bartoli, S | 1 |
| Puce, E | 1 |
| Palombi, M | 1 |
| Thau, A | 1 |
| Pozzar, F | 1 |
| Pau, F | 1 |
| Lindblad, B | 1 |
| Wakefield, TW | 1 |
| Stanley, TJ | 1 |
| Bergqvist, D | 1 |
| Nichol, BJ | 1 |
| Greenfield, LJ | 1 |
| Stanley, JC | 1 |
| Bergentz, SE | 1 |
| Bajnok, L | 1 |
| Kozlovszky, B | 1 |
| Varga, J | 1 |
| Antalffy, J | 1 |
| Olvasztó, S | 1 |
| Fülöp, T | 1 |
| Edmondson, RA | 1 |
| Cohen, AT | 1 |
| Das, SK | 1 |
| Wagner, MB | 1 |
| Kakkar, VV | 1 |
| Schueppert, MT | 1 |
| Kresowik, TF | 2 |
| Corry, DC | 1 |
| Jacobovicz, C | 1 |
| Mohan, CR | 1 |
| Slaymaker, E | 1 |
| Hoballah, JJ | 2 |
| Sharp, WJ | 2 |
| Grover-McKay, M | 1 |
| Corson, JD | 2 |
| Massie, MT | 1 |
| Rohrer, MJ | 1 |
| Leppo, JA | 1 |
| Cutler, BS | 1 |
| Rossi, E | 1 |
| Citterio, F | 1 |
| Vescio, MF | 1 |
| Pennestri, F | 1 |
| Lombardo, A | 1 |
| Loperfido, F | 1 |
| Maseri, A | 1 |
| Safi, AM | 1 |
| Pillai, N | 1 |
| Rachko, M | 1 |
| Chaudhry, K | 1 |
| Stein, RA | 1 |
| Matsagas, MI | 1 |
| Geroulakos, G | 1 |
| Mikhailidis, DP | 1 |
| Beller, GA | 1 |
| Saniabadi, AR | 1 |
| Fisher, TC | 1 |
| Lau, CS | 1 |
| Bridges, A | 1 |
| Taylor, J | 1 |
| Belch, J | 1 |
| Forbes, CD | 1 |
| Koch, M | 1 |
| Viaud, JF | 1 |
| Cittone, S | 1 |
| Douard, H | 1 |
| Oysel, N | 1 |
| Broustet, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Prolonged Dual Antiplatelet Therapy With Clopidogrel Plus Acetylsalicylic Acid (ASA) After Percutaneous Lower Extremity Revascularization in Patients With Peripheral Arterial Disease[NCT02798913] | Phase 3 | 300 participants (Anticipated) | Interventional | 2016-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for dipyridamole and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Topics: Anastomosis, Surgical; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vas | 2015 |
Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggre | 2009 |
Antiplatelet therapy in peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Humans; Peripheral Vascular Disease | 2004 |
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopido | 2004 |
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Dipyridamole; Humans; Peripheral Vascular Diseases; P | 2005 |
[Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Evidence-Based Medici | 2007 |
The role of platelets in peripheral arterial disease: therapeutic implications.
Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Peripheral Vascular Diseases; | 2002 |
2 trials available for dipyridamole and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Dipyridamole echocardiography and 99mTc-MIBI spect dipyridamole scintigraphy for cardiac evaluation prior to peripheral vascular surgery.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Coronary Disease; Dipyridamole; Echocardiograph | 1995 |
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting.
Topics: Adult; Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusi | 1994 |
14 other studies available for dipyridamole and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Aspirin for prevention of stroke and cardiovascular events among patients with peripheral artery disease.
Topics: Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Peripheral Vascular Diseases; Platelet Aggre | 2009 |
Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway.
Topics: Animals; Cell Division; Chronic Disease; Cyclic AMP-Dependent Protein Kinases; Dipyridamole; Dose-Re | 2010 |
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bl | 2003 |
Negative predictive value of dipyridamole vs. dobutamine stress echocardiography in the long-term follow-up of patients undergoing major vascular surgery.
Topics: Aged; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography, Stress; Female; Follow-Up Stud | 2004 |
Pharmacological prophylaxis against postoperative graft occlusion after peripheral vascular surgery: a world-wide survey.
Topics: Anticoagulants; Aspirin; Data Collection; Dipyridamole; Drug Utilization; Graft Occlusion, Vascular; | 1995 |
Technetium-99m sestamibi scintigraphy for the assessment of lower extremity ischaemia in peripheral arterial disease.
Topics: Dipyridamole; Female; Heart; Humans; Ischemia; Leg; Male; Middle Aged; Peripheral Vascular Diseases; | 1994 |
Selection of patients for cardiac evaluation before peripheral vascular operations.
Topics: Aged; Coronary Angiography; Coronary Disease; Dipyridamole; Elective Surgical Procedures; Evaluation | 1996 |
Cardiac screening tests prior to lower extremity revascularization: routine versus selective application.
Topics: Coronary Disease; Dipyridamole; Heart Function Tests; Humans; Inguinal Canal; Ischemia; Leg; Periphe | 1997 |
Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans?
Topics: Case-Control Studies; Coronary Angiography; Coronary Disease; Dipyridamole; Female; Heart; Humans; M | 1997 |
Risk stratification of patients undergoing peripheral vascular revascularization by combined resting and dipyridamole echocardiography.
Topics: Aged; Aged, 80 and over; Dipyridamole; Echocardiography; Exercise Test; Female; Follow-Up Studies; H | 1998 |
Dipyridamole-induced ST-segment elevation indicative of transmural myocardial ischemia--a case report.
Topics: Coronary Angiography; Dipyridamole; Electrocardiography; Follow-Up Studies; Humans; Male; Middle Age | 2001 |
Are you ever too old to be risk stratified?
Topics: Age Factors; Aged; Coronary Disease; Dipyridamole; Exercise Test; Heart; Humans; Middle Aged; Periph | 1992 |
Dipyridamole increases human red blood cell deformability.
Topics: Adult; Aged; Dipyridamole; Erythrocyte Deformability; Female; Humans; Kidney Failure, Chronic; Male; | 1992 |
[Which coronary investigation should be performed in patients with peripheral arterial diseases?].
Topics: Coronary Angiography; Coronary Disease; Decision Trees; Dipyridamole; Electrocardiography; Exercise | 1991 |